कृपया अन्य खोज का प्रयास करें
GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Andrea Small-Howard | 54 | 2014 | Chairman of Scientific Advisory Board, Chief Science Officer, President & Director |
Helen Turner | - | 2014 | Member of Scientific Advisory Board |
Norbert E. Kaminski | - | - | Member of Scientific Advisory Board |
Carlos F. Rios-Bedoya | - | - | Member of Scientific Advisory Board |
John Claybron Poss | 75 | 2015 | CEO, Interim CFO & Chairman |
Alexander Stokes | - | - | Member of Scientific Advisory Board |
Edmond A. DeFrank | 55 | 2019 | Independent Director |
Zoltan Mari | - | 2018 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है